Surgical Courses: Opportunities to Improve Your Skills
Surgical exposure varies tremendously between residency programs. For those interested in a career in Mohs surgery, additional training in more complex techniques can be helpful before you start (or even during) your fellowship. Even for residents interested in general or pediatric dermatology, having expert guidance on surgical fundamentals can help ensure you are comfortable after you finish tra …
Surgical exposure varies tremendously between residency programs. For those interested in a career in Mohs surgery, additional training in more complex techniques can be helpful before you start (or even during) your fellowship. Even for residents interested in general or pediatric dermatology, having expert guidance on surgical fundamentals can help ensure you are comfortable after you finish tra … Continue reading "Surgical Courses: Opportunities to Improve Your Skills"
Colchicine, a microtubule polymerization inhibitor, was first described for use in treating joint pain and swelling in ancient Egypt and has since become a mainstay in the medical management of gout. Beyond its indicated uses, it has numerous off-label dermatologic applications, particularly for neutrophilic and autoimmune conditions. As a potent anti-inflammatory, colchicine requires careful lab … 
Social media is a major source of medical information, including information about hair loss. How reliable is the hair loss material presented on social media, and how does this information impact patients? Those are some of the questions posed by researchers in a study published in the March Journal of Drugs in Dermatology.
I interviewed author Raymond Ezzat, third-year medical student at Geor … 
Typical dermoscopic features of this common benign lesion that typically begins to appear during the fourth decade of life include all of the following except:
A. Fat fingers
B. Reticulated pigment network
C. Milia-like cysts
D. Cerebriform surface
E. Light brown parallel structures
To find out the correct answer and r … 
The past year has been an extraordinary time in drug approvals in medical dermatology, especially the approval of treatments that impact patients with skin of color, according to Dr. Andrew F. Alexis, co-chair of Skin of Color Update. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Alexis, who is also vice-chair for diversity and inclusion for the Weill Cornell Medica …